← Evidence map

TrialMedicina (Kaunas, Lithuania)2024

Comparing the Risk of Infusion-Related Reactions and Tolerability in Patients Given Cetirizine or Diphenhydramine Prior to Ocrelizumab Infusion (PRECEPT).

Kyle Smoot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2024
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 38674305